Does a BMI of 30 mean I can get a GLP-1?

Not by itself. A prescriber looks at your health as a whole, and coverage rules vary.

Why are Japan’s figures different?

Each country’s regulator approves its own label. Japan’s label sets its own BMI figures and conditions.

You can, though a falling BMI isn’t a reason to change a dose on your own. Talk to your prescriber.

BMI = weight in kg ÷ (height in cm ÷ 100)². For example, 90 kg and 180 cm gives a BMI of 27.8 kg/m² after rounding.

The math

BMI = weight in kg ÷ (height in m)²BMI ≈ weight in lb ÷ (height in inches)² × 703BMI = (weight in lb × 0.45359237) ÷ (height in inches × 0.0254)²

CDC gives both forms, with this example: an adult who is 5 feet 8 inches and weighs 200 pounds has a BMI of 30.4.⁸⁹¹⁰

Label region	BMI figures it names
EU	30 or more, or 27 to under 30 with at least one weight-related condition⁴
Japan, semaglutide for weight management	35 or more, or 27 or more with two or more obesity-related conditions, and only with high blood pressure, dyslipidemia or type 2 diabetes after diet and exercise⁶

Before you act on this

BMI doesn’t measure body fat or health directly, and it reads differently across ages, bodies and backgrounds.

A number on this page doesn’t mean a medicine is or isn’t right for you. Talk to your prescriber.

Always follow your doctor’s or prescriber’s advice and guidance. Talk to your prescriber before changing your dose.

For information only, not medical advice. Verify results with your healthcare provider; Onederland accepts no liability for use of these tools.

Sources

NIST: exact unit conversion factors. nist.gov
Wegovy (semaglutide) injection and tablets, US prescribing information, revised 06/2026. accessdata.fda.gov
Zepbound (tirzepatide) injection, US prescribing information, revised 08/2026. accessdata.fda.gov
EU product information for semaglutide for weight management (tablets: summary of product characteristics, section 4.2), updated 21 September 2026. ema.europa.eu
EU product information: tirzepatide. ema.europa.eu
Japanese prescribing information: injectable semaglutide for obesity, June 2026. pmda.go.jp
Japanese prescribing information: tirzepatide for obesity, September 2026. pmda.go.jp
CDC: BMI formulas. cdc.gov
CDC: adult BMI categories. cdc.gov
CDC: BMI frequently asked questions. cdc.gov

Label sources last checked on October 30, 2026. Onederland summarizes them; your prescriber and the full prescribing information come first.